Predictors of resolution of hypertension after adrenalectomy in patients with aldosterone-producing adenoma

Journal of Korean Medical Science

Volumn 25, Issue 7, 2010, Pages 1041-1044

  Kim, Ra Mi ^a   Lee, Jandee ^a   Soh, Euy Young ^a  

^a Ajou University School of Medicine   (South Korea)

Author keywords

Adrenal glands; Primary aldosteronism; Resistant hypertension

Indexed keywords

ALDOSTERONE;

ADRENAL CORTEX ADENOMA; ADRENALECTOMY; ADULT; ARTICLE; BLOOD; FEMALE; HUMAN; HYPERALDOSTERONISM; HYPERTENSION; MALE; MIDDLE AGED; RETROSPECTIVE STUDY; TREATMENT OUTCOME; ADRENOCORTICAL ADENOMA; COMPLICATION;

ADRENALECTOMY; ADRENOCORTICAL ADENOMA; ADULT; ALDOSTERONE; FEMALE; HUMANS; HYPERALDOSTERONISM; HYPERTENSION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 77956517779     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2010.25.7.1041     Document Type: Article

References (26)

1. Streeten DH, Anderson GH. Secondary hypertension. An overview of its causes and management. Drugs 1992; 43: 805-19.
2. Young WF Jr. Primary aldosteronism: a common and curable form of hypertension. Cardiol Rev 1999; 7: 207-14.
3. Lund JO, Nielsen MD, Giese J. Prevalence of primary aldosteronism. Acta Med Scand Suppl 1981; 646: 54-7.
4. Anderson GH Jr, Blakeman N, Streeten DH. The effect of age on prevalence of secondary forms of hypertension in 4429 consecutively referred patients. J Hypertens 1994; 12: 609-15.
5. Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C, Ganzaroli C, Giacchetti G, Letizia C, Maccario M, Mallamaci F, Mannelli M, Mattarello MJ, Moretti A, Palumbo G, Parenti G, Porteri E, Semplicini A, Rizzoni D, Rossi E, Boscaro M, Pessina AC, Mantero F. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol 2006; 48: 2293-300.
6. Zarnegar R, Young WF Jr, Lee J, Sweet MP, Kebebew E, Farley DR, Thompson GB, Grant CS, Clark OH, Duh QY. The Aldosteronoma resolution score predicting complete resolution of hypertension after adrenalectomy for aldosteronoma. Ann Surg 2008; 247: 511-8.
7. Catena C, Colussi G, Nadalini E, Chiuch A, Baroselli S, Lapenna R, Sechi LA. Cardiovascular outcomes in patients with primary aldosteronism after treatment. Arch Intern Med 2008; 168: 80-5.
8. Pang TC, Bambach C, Monaghan JC, Sidhu SB, Bune A, Delbridge LW, Sywak MS. Outcomes of laparoscopic adrenalectomy for hyperladosteronism. ANZ Surg 2007; 77: 768-73.
9. Sawka AM, Young WF, Thompson GB, Grant CS, Farley DR, Leibson C, van Heerden JA. Primary aldosteronism: factors associated with normalization of blood pressure after surgery. Ann Intern Med 2001; 135: 258-61.
10. Blumenfeld JD, Sealey JE, Schlussel Y, Vaughan ED Jr, Sos TA, Atlas SA, Müller FB, Acevedo R, Ulick S, Laragh JH. Diagnosis and treatment of primary hyperaldosteronism. Ann Intern Med 1994; 121: 877-85.
11. Rayner B. Primary aldosteronism and aldosterone-associated hypertension. J Clin Pathol 2008; 61: 825-31.
12. Douma S, Petidis K, Doumas M, Papaefthimiou P, Triantafyllou A, Kartali N, Papadopoulos N, Vogiatzis K, Zamboulis C. Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study. Lancet 2008; 371: 1921-6.
13. Rossi GP, Pessina AC. Blood pressure outcome of adrenalectomy in patients with primary hyperaldosteronism with or without unilateral adenoma. J Hypertens 2009; 27: 656-9.
14. Carey RM. Primary aldosteronism. Horm Res 2009; 71 (Suppl 1): 8-12.
15. Gaddam KK, Pimenta E, Husain S, Calhoun DA. Aldosterone and cardiovascular disease. Curr Probl Cardiol 2009; 34: 51-84.
16. Conn JW, Louis LH. Primary aldosteronism, a new clinical entity. Ann Intern Med 1956; 44: 1-15.
17. Calhoun DA. Aldosteronism and hypertension. Clin J Am Soc Nephrol 2006; 1: 1039-45.
18. Loh KC, Koay ES, Emmanuel SC, Young WF Jr. Prevalence of primary aldosteronism among Asian hypertensive patient in Singapore. J Clin Endocrinol Metab 2000; 85: 2854-9.
19. Plouin PF, Amar L, Chatellier G. Trends in the prevalence of primary aldosteronism, alsoterone-producing adenomas, and surgically correctable aldosterone-dependent hypertension. Nephrol Dial Transplant 2004; 19: 774-7.
20. Rossi GP. Primary aldosteronism: a needle in a haystack or a yellow cab on Fifth Avenue? Curr Hypertens Rep 2004; 6: 1-4.
21. Young WF Jr. Primary aldosteronism: update on diagnosis and treatment. Endocrinologist 1997; 7: 213-21.
22. Ganguly A. Primary aldosteronism. N Engl J Med 1998: 17; 339: 1828-34.
23. Rocha R, Martin-Berger CL, Yang P, Scherrer R, Delyani J, McMahon E. Selective aldosterone blockade prevents angiotensin II/salt induced vascular inflammation in the rat heart. Endocrinology 2002; 143: 4828-36.
24. Chang MC, Noh DY, Youn YK, Choe KJ, Oh SK. Factors influencing outcome of surgical treatment for primary aldosteronism. J Korean Surg Soc 2002; 62: 308-13.
25. Reincke M, Rump LC, Quinkler M, Hahner S, Diederich S, Lorenz R, Seufert J, Schirpenbach C, Beuschlein F, Bidlingmaier M, Meisinger C, Holle R, Endres S. Risk factors associated with a low glomerular filtration rate in primary aldosteronism. J Clin Endocrinol Metab 2009; 94: 869-75.
26. Mourad JJ, Girerd X, Milliez P, Lopez-Sublet M, Lejeune S, Safar ME. Urinary aldosterone-to-active-renin ratio: a useful tool for predicting resolution of hypertension after adrenalectomy in patients with aldosterone-producing adenomas. Am J Hypertens 2008; 21: 742-7.